MI 2 (Menin-MLL Inhibitor)

  Cat. No.:  DC7621   Featured
Chemical Structure
1271738-62-5
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
MI-2 is an inhibitor of MALT1 with IC50 value of 5.84 μM.
Cas No.: 1271738-62-5
Chemical Name: 4-(4-(5,5-Dimethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-propylthieno[2,3-d]pyrimidine
Synonyms: 4-(4-(5,5-Dimethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-propylthieno[2,3-d]pyrimidine;MI-2;4-(4-(5,5-Dimethyl-4,5-dihydrothiazol-2-yl)-piperazin-1-yl)-6-propylthieno[2,3-d]pyrimidine;MI-?2;MI-2 (Menin-MLL Inhibitor);AK118880;CS-0771;HY-15222;Menin-MLL inhibitor 2;QCR-218;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-;4-[4-(5,5-dimethyl-4H-1,3-thiazol-2-yl)piperazin-1-yl]-6-propylthieno[2,3-d]pyrimidine;4-[4-(5,5-Dimethyl-4,5-Dihydro-1,3-Thiazol-2-Yl)piperazin-1-Yl]-6-Propylthieno[2,3-D]pyrimidine;mi-2-menin-mll-inhibitor;MI 2 (Menin-MLL Inhibitor);MI-2, Menin-MLL inhibitor 2;AOB1818;Menin-MLL inhibitor MI-2
SMILES: S1C(=NC([H])([H])C1(C([H])([H])[H])C([H])([H])[H])N1C([H])([H])C([H])([H])N(C2=C3C([H])=C(C([H])([H])C([H])([H])C([H])([H])[H])SC3=NC([H])=N2)C([H])([H])C1([H])[H]
Formula: C18N5S2H25
M.Wt: 375.5546
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: MI-2 is a Menin-MLL interaction inhibitor with IC50 of 446±28 nM.
In Vitro: The menin-MLL inhibitor MI-2 very effectively blocks proliferation of MLL-AF9 and MLL-ENL transduced BMC, with GI50 values of about 5 μM. Assessment of diverse hydrophobic groups at R1 led to the development of several compounds with IC50 values in the nanomolar range, including MI-2 (IC50= 446±28 nM) and MI-3 (IC50=648±25 nM).The dissociation constants measured for the menin-MLL inhibitors are at the nanomolar level, Kd=158 nM for MI-2. MI-2 can access the protein target and very effectively inhibit the menin-MLL-AF9 interaction in human cells. Furthermore, MI-2 shows only a small effect on the cell growth of E2A-HLF transduced BMC (GI50>50 μM), which may be due to inhibition of the menin interaction with wild-type MLL. Treatment with MI-2 results in GI50 values below 10 μM in MV4;11 (harboring MLL-AF4; GI50=9.5 μM), KOPN-8 (MLL-ENL; GI50=7.2 μM) and ML-2 (MLL-AF6; GI50=8.7 μM), and in MonoMac6 (MLL-AF9; GI50=18 μM)[1].
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC48250 MLT-985 MLT-985 is a highly selective allosteric MALT1 inhibitor with an IC50 value of 3 nM.
DC42356 MLT-231 MLT-231 is a potent, highly selective allosteric MALT1 with an IC50 of 9 nM. MLT-231 specifically prevents endogenous BCL10 cleavage with IC50 of 160 nM. MLT-231 shows antitumor activity in an ABC-DLBCL type xenograft model in mouse.
DC7621 MI 2 (Menin-MLL Inhibitor) MI-2 is an inhibitor of MALT1 with IC50 value of 5.84 μM.
DC9503 MI 2 (MALT1 inhibitor) MI 2(MALT1 inhibitor) is a small molecule and irreversible inhibitor of MALT1 with IC50 of 5.84 uM(suppression of proliferation in ABCDLBCL).
X